project id: TCGA-BLCA; case submitter id: TCGA-FD-A3B3; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 7.6; age at index: 74; days to birth: -27068; days to death: 974; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1937; age at diagnosis: 27068; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 392.0; icd 10 code: C67.0; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Trigone of bladder; synchronous malignancy: No; tissue or organ of origin: Trigone of bladder; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.7534246575342465; pack years smoked: 32.0; is ffpe: false; composition: Not Reported; days to collection: 182; days to sample procurement: 0; initial weight: 270.0; portion submitter id: TCGA-FD-A3B3-01A-12; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 75.0;